how many people use semaglutide Ozempic Statistics: GLP-1 Weight Loss Medication Data Semaglutide: The benefits and risks

In January 2026, an IGD ShopperVista report found that 5.2% of respondents say they have personally used weight loss drugs, an increase of 1% from September 2025

[] Eicosanoids generated from arachidonic acid promote inflammation, while those derived from omega-3 fatty acids exhibit anti-inflammatory effects, which can help prevent PCa

I also consider other factors, including other medications you take, chronic illnesses (like cancer or diabetes), family history, how much weight you want to lose, and your preferred mode of taking your medication

Additional info National Heart, Lung, and Blood Institute (NHLBI) About the Reviewer Howard E